The company’s annual meeting resulted in the election of directors, ratification of an accounting firm, and approval of the reverse stock split amendment. More about Conduit Pharmaceuticals YTD ...
Conduit Pharmaceuticals Inc ... meeting held on Wednesday approved an amendment allowing for a reverse stock split at a ratio of not less than 1-for-10 and not more than 1-for-100, at the ...
Conduit Pharmaceuticals Inc. (NASDAQ:CDT), a Delaware-based pharmaceutical company ... In an attempt to address the issue, stockholders at the company's annual meeting held on Wednesday approved an ...